Testosterone and nucleus accumbens dopamine in the male Syrian hamster

Psychoneuroendocrinology

Volumn 33, Issue 3, 2008, Pages 386-394

  Triemstra, Jennifer L ^a   Sato, Satoru M ^a   Wood, Ruth I ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Amphetamine; Anabolic androgenic steroid; Dopamine; Hamster; HPLC EC; Intracerebroventricular; Microdialysis; Nucleus accumbens; Subcutaneous; Testosterone

Indexed keywords

AMPHETAMINE; DOPAMINE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG ABUSE; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SYRIAN HAMSTER;

AMPHETAMINE; ANIMALS; CRICETINAE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; INJECTIONS, INTRAVENTRICULAR; MALE; MESOCRICETUS; MICRODIALYSIS; NUCLEUS ACCUMBENS; TESTOSTERONE;

EID: 39149142838     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.12.006     Document Type: Article

References (83)

1. Agren G., Thiblin I., Tirassa P., Lundeberg T., and Stenfors C. Behavioural anxiolytic effects of low-dose anabolic androgenic steroid treatment in rats. Physiol. Behav. 66 (1999) 503-509
2. Aikey J.L., Nyby J.G., Anmuth D.M., and James P.J. Testosterone rapidly reduces anxiety in male house mice (Mus musculus). Horm. Behav. 42 (2002) 448-460
3. Arnedo M.T., Salvador A., Martinez-Sanchis S., and Gonzalez-Bono E. Rewarding properties of testosterone in intact male mice: a pilot study. Pharmacol. Biochem. Behav. 65 (2000) 327-332
4. Ballard C.L., and Wood R.I. Intracerebroventricular self-administration of commonly abused anabolic-androgenic steroids in male hamsters (Mesocricetus auratus): nandrolone, drostanolone, oxymetholone, and stanozolol. Behav. Neurosci. 119 (2005) 752-758
5. Barreto-Estrada J.L., Barreto J., Fortis-Santiago Y., Rivera-Ramos I., Fortis-Santiago A., and Jorge J.C. Modulation of affect after chronic exposure to the anabolic steroid 17alpha-methyltestosterone in adult mice. Behav. Neurosci. 118 (2004) 1071-1079
6. Becker J.B., and Rudick C.N. Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study. Pharmacol. Biochem. Behav. 64 (1999) 53-57
7. Belelli D., Herd M.B., Mitchell E.A., Peden D.R., Vardy A.W., Gentet L., and Lambert J.J. Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience 138 (2006) 821-829
8. Berbos Z.J., Chu L., and Wood R.I. Acute behavioral effects of anabolic steroids: anxiety, stereotypy and locomotor activity. Horm. Behav. 41 (2002) 457
9. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res.-Brain Res. Rev. 28 (1998) 309-369
10. Bhasin S., Storer T.W., Berman N., Callegari C., Clevenger B., Phillips J., Bunnell T.J., Tricker R., Shirazi A., and Casaburi R. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men [see comment]. N. Engl. J. Med. 335 (1996) 1-7
11. Birgner C., Kindlundh-Hogberg A.M., Nyberg F., and Bergstrom L. Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge. Neurosci. Lett. 412 (2007) 168-172
12. Brower K.J. Anabolic steroid abuse and dependence. Curr. Psychiatr. Rep. 4 (2002) 377-387
13. Bruning P.F., Jonker K.M., and Boerema-Baan A.W. Adsorption of steroid hormones by plastic tubing. J. Steroid Biochem. 14 (1981) 553-555
14. Caine S.B., and Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270 (1995) 209-218
15. Carlezon Jr. W.A., and Wise R.A. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J. Neurosci. 16 (1996) 3112-3122
16. Celerier E., Yazdi M.T., Castane A., Ghozland S., Nyberg F., and Maldonado R. Effects of nandrolone on acute morphine responses, tolerance and dependence in mice. Eur. J. Pharmacol. 465 (2003) 69-81
17. Clark A.S., and Henderson L.P. Behavioral and physiological responses to anabolic-androgenic steroids. Neurosci. Biobehav. Rev. 27 (2003) 413-436
18. Clark A.S., Lindenfeld R.C., and Gibbons C.H. Anabolic-androgenic steroids and brain reward. Pharmacol. Biochem. Behav. 53 (1996) 741-745
19. Cunningham C.L., Malott D.H., Dickinson S.D., and Risinger F.O. Haloperidol does not alter expression of ethanol-induced conditioned place preference. Behav. Brain Res. 50 (1992) 1-5
20. Di Chiara G., and Imperato A. Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur. J. Pharmacol. 115 (1985) 131-132
21. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85 (1988) 5274-5278
22. DiMeo A.N., and Wood R.I. ICV testosterone induces Fos in male Syrian hamster brain. Psychoneuroendocrinology 31 (2006) 237-249
23. DiMeo A.N., and Wood R.I. Self-administration of estrogen and dihydrotestosterone in male hamsters. Horm. Behav. 49 (2006) 519-526
24. DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders. Text Revision. fourth ed (2000), American Psychiatric Association, Washington, DC
25. Ferry A., Noirez P., Page C.L., Salah I.B., Daegelen D., and Rieu M. Effects of anabolic/androgenic steroids on regenerating skeletal muscles in the rat. Acta Physiol. Scand. 166 (1999) 105-110
26. File S.E. Aversive and appetitive properties of anxiogenic and anxiolytic agents. Behav. Brain Res. 21 (1986) 189-194
27. Finlay J.M., Damsma G., and Fibiger H.C. Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration. Psychopharmacology (Berlin) 106 (1992) 202-208
28. Frye C.A., and Reed T.A. Androgenic neurosteroids: anti-seizure effects in an animal model of epilepsy. Psychoneuroendocrinology 23 (1998) 385-399
29. Frye C.A., and Seliga A.M. Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats. Cogn. Affect. Behav. Neurosci. 1 (2001) 371-381
30. Frye C.A., Van Keuren K.R., Rao P.N., and Erskine M.S. Analgesic effects of the neurosteroid 3 alpha-androstanediol. Brain Res. 709 (1996) 1-9
31. Frye C.A., Babson A., and Walf A.A. Self-administration of 3alph-androstanediol increases locomotion and analgesia and decreases aggressive behavior of male hamster. Pharmacol. Biochem. Behav. 86 (2007) 415-421
32. Glick S.D., Maisonneuve I.M., Raucci J., and Archer S. Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res. 681 (1995) 147-152
33. Grimes J.M., Ricci L.A., and Melloni Jr. R.H. Glutamic acid decarboxylase (GAD65) immunoreactivity in brains of aggressive, adolescent anabolic steroid-treated hamsters. Horm. Behav. 44 (2003) 271-280
34. Imperato A., Mulas A., and Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132 (1986) 337-338
35. Invernizzi R., Pozzi L., and Samanin R. Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats. Neuropharmacology 30 (1991) 575-578
36. Johansson P., Ray A., Zhou Q., Huang W., Karlsson K., and Nyberg F. Anabolic androgenic steroids increase beta-endorphin levels in the ventral tegmental area in the male rat brain. Neurosci. Res. 27 (1997) 185-189
37. Johansson P., Hallberg M., Kindlundh A., and Nyberg F. The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate. Brain Res. Bull. 51 (2000) 413-418
38. Johansson P., Lindqvist A., Nyberg F., and Fahlke C. Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. Pharmacol. Biochem. Behav. 67 (2000) 271-279
39. Johnson L.R., and Wood R.I. The ventral striatum of the Syrian hamster. Ann. N. Y. Acad. Sci. 877 (1999) 661-666
40. Johnson L.R., and Wood R.I. Oral testosterone self-administration in male hamsters. Neuroendocrinology 73 (2001) 285-292
41. Kalivas P.W., Widerlov E., Stanley D., Breese G., and Prange Jr. A.J. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J. Pharmacol. Exp. Ther. 227 (1983) 229-237
42. Kindlundh A.M., Rahman S., Lindblom J., and Nyberg F. Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration. Neurosci. Lett. 356 (2004) 131-134
43. Koob G.F., and Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9 (1997) 482-497
44. Kouri E.M., Lukas S.E., Pope Jr. H.G., and Oliva P.S. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depen. 40 (1995) 73-79
45. Kritzer M.F. Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat. J. Comp. Neurol. 379 (1997) 247-260
46. Leshner, A.I., 2000. Anabolic Steroid Abuse. NIDA Research Report Series, pp. 1-8.
47. Marinelli M., Barrot M., Simon H., Oberlander C., Dekeyne A., Le Moal M., and Piazza P.V. Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential. Eur. J. Neurosci. 10 (1998) 3269-3275
48. Martinez-Sanchis S., Salvador A., Moya-Albiol L., Gonzalez-Bono E., and Simon V.M. Effects of chronic treatment with testosterone propionate on aggression and hormonal levels in intact male mice. Psychoneuroendocrinology 23 (1998) 275-293
49. Masonis A.E., and McCarthy M.P. Direct effects of the anabolic/androgenic steroids, stanozolol and 17 alpha-methyltestosterone, on benzodiazepine binding to the gamma-aminobutyric acid(a) receptor. Neurosci. Lett. 189 (1995) 35-38
50. Masonis A.E., and McCarthy M.P. Effects of the androgenic/anabolic steroid stanozolol on GABAA receptor function: GABA-stimulated 36Cl-influx and [35S] TBPS binding. J. Pharmacol. Exp. Ther. 279 (1996) 186-193
51. Menard C.S., Hebert T.J., Dohanich G.P., and Harlan R.E. Androgenic-anabolic steroids modify beta-endorphin immunoreactivity in the rat brain. Brain Res. 669 (1995) 255-262
52. Morin L.P., and Wood R.I. A Stereotaxic Atlas of the Golden Hamster Brain (2001), Academic Press, New York
53. Naruse T., and Asami T. Intravenous self-administration of diazepam in rats. Eur. J. Pharmacol. 135 (1987) 365-373
54. NHANES, 2007. 〈www.cdc.gov/od/oc/media/pressrel/r041027.htm〉, accessed 7/18/07.
55. Packard M.G., Cornell A.H., and Alexander G.M. Rewarding affective properties of intra-nucleus accumbens injections of testosterone. Behav. Neurosci. 111 (1997) 219-224
56. Packard M.G., Schroeder J.P., and Alexander G.M. Expression of testosterone conditioned place preference is blocked by peripheral or intra-accumbens injection of alpha-flupenthixol. Horm. Behav. 34 (1998) 39-47
57. Penatti C.A., Porter D.M., Jones B.L., and Henderson L.P. Sex-specific effects of chronic anabolic androgenic steroid treatment on GABA(A) receptor expression and function in adolescent mice. Neuroscience 135 (2005) 533-543
58. Pert A., and Sivit C. Neuroanatomical focus for morphine and enkephalin-induced hypermotility. Nature 265 (1977) 645-647
59. Peters K.D., and Wood R.I. Androgen dependence in hamsters: overdose, tolerance, and potential opioidergic mechanisms. Neuroscience 130 (2005) 971-981
60. Pettit H.O., Ettenberg A., Bloom F.E., and Koob G.F. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berlin) 84 (1984) 167-173
61. Pope Jr. H.G., and Katz D.L. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch. Gen. Psychiatry 51 (1994) 375-382
62. Rassnick S., Stinus L., and Koob G.F. The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res. 623 (1993) 16-24
63. Risinger F.O., Dickinson S.D., and Cunningham C.L. Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference. Psychopharmacology (Berlin) 107 (1992) 453-456
64. Roberts D.C., Corcoran M.E., and Fibiger H.C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6 (1977) 615-620
65. Rojas-Ortiz Y.A., Rundle-Gonzalez V., Rivera-Ramos I., and Jorge J.C. Modulation of elevated plus maze behavior after chronic exposure to the anabolic steroid 17alpha-methyltestosterone in adult mice. Horm. Behav. 49 (2006) 123-128
66. Sato, S.M., Johansen, J., Jordan, C.L., Wood, R.I., 2006. Androgen self-administration in Tfm rats. 10th Annual Meeting of Society for Behavioral Neuroendocrinology, Pittsburgh, PA
67. Schenk S., Partridge B., and Shippenberg T.S. U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology (Berlin) 144 (1999) 339-346
68. Simerly R.B., Chang C., Muramatsu M., and Swanson L.W. Distribution of androgen and estrogen mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294 (1990) 76-95
69. Simoncini T., and Genazzani A.R. Non-genomic actions of sex steroid hormones. Eur. J. Endocrinol. 148 (2003) 281-292
70. Spanagel R. Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav. Brain Res. 70 (1995) 37-49
71. Spyraki C., and Fibiger H.C. A role for the mesolimbic dopamine system in the reinforcing properties of diazepam. Psychopharmacology (Berlin) 94 (1988) 133-137
72. Spyraki C., Kazandjian A., and Varonos D. Diazepam-induced place preference conditioning: appetitive and antiaversive properties. Psychopharmacology (Berlin) 87 (1985) 225-232
73. Szostak C., Finlay J.M., and Fibiger H.C. Intravenous self-administration of the short-acting benzodiazepine midazolam in the rat. Neuropharmacology 26 (1987) 1673-1676
74. Thiblin I., Finn A., Ross S.B., and Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids. Br. J. Pharmacol. 126 (1999) 1301-1306
75. Tricker R., Casaburi R., Storer T.W., Clevenger B., Berman N., Shirazi A., and Bhasin S. The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men-a clinical research center study. J. Clin. Endocrinol. Metab. 81 (1996) 3754-3758
76. Vaccarino F.J., Amalric M., Swerdlow N.R., and Koob G.F. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacol. Biochem. Behav. 24 (1986) 61-65
77. Weir C.J., Ling A.T., Belelli D., Wildsmith J.A., Peters J.A., and Lambert J.J. The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors. Br. J. Anaesth. 92 (2004) 704-711
78. Wood R.I. Oral testosterone self-administration in male hamsters: dose-response, voluntary exercise, and individual differences. Horm. Behav. 41 (2002) 247-258
79. Wood R.I., and Newman S.W. Androgen and estrogen receptors coexist within individual neurons in the brain of the Syrian hamster. Neuroendocrinology 62 (1995) 487-497
80. Wood R.I., Johnson L.R., Chu L., Schad C., and Self D.W. Testosterone reinforcement: intravenous and intracerebroventricular self-administration in male rats and hamsters. Psychopharmacology (Berlin) 171 (2004) 298-305
81. WorldAnti-DopingAgency. Adverse analytical findings reported by accredited laboratories (2006), World Anti-Doping Agency, Montreal, Canada
82. Yesalis C.E., Kennedy N.J., Kopstein A.N., and Bahrke M.S. Anabolic-androgenic steroid use in the United States. JAMA 270 (1993) 1217-1221
83. Zetterstrom T., and Fillenz M. Local administration of flurazepam has different effects on dopamine release in striatum and nucleus accumbens: a microdialysis study. Neuropharmacology 29 (1990) 129-134